Comment on "Antipsoriatic treatments during COVID-19 outbreak"

Ayman Abdelmaksoud¹, Mohamad Goldust^{2

3

4}, Michelangelo Vestita^{5

6}

Affiliations

¹ Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
² Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
³ Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
⁴ Department of Dermatology, University Hospital Basel, Basel, Switzerland.
⁵ Unit of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
⁶ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Comment

Ayman Abdelmaksoud et al. Dermatol Ther. 2020 Jul.

. 2020 Jul;33(4):e13491.

doi: 10.1111/dth.13491. Epub 2020 Jun 12.

Ayman Abdelmaksoud¹, Mohamad Goldust^{2

3

4}, Michelangelo Vestita^{5

6}

¹ Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
² Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
³ Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
⁴ Department of Dermatology, University Hospital Basel, Basel, Switzerland.
⁵ Unit of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
⁶ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Comment on

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.
Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. Conforti C, et al. Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22. Dermatol Ther. 2020. PMID: 32157783 Free PMC article. No abstract available.
Antipsoriatic treatments during COVID-19 outbreak.
Di Lernia V. Di Lernia V. Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10. Dermatol Ther. 2020. PMID: 32223073 Free PMC article. No abstract available.

1. Di Lernia V. Antipsoriatic treatments during COVID‐19 outbreak. Dermatol Ther. 2020;29:e13345. 10.1111/dth.13345. - DOI - PMC - PubMed
1. Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020;11:e13298. 10.1111/dth.13298. - DOI - PMC - PubMed
1. Abdelmaksoud A, Goldust M, Vestita M. Comment on “COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action”. Dermatol Ther. 2020;1:e13360. 10.1111/dth.13360. - DOI - PMC - PubMed
1. Rademaker M, Agnew K, Anagnostou N, et al. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol. 2019;60(2):91‐98. - PubMed
1. Sbidian E, Madrange M, Viguier M, et al. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol. 2019;181(6):1304‐1306. - PMC - PubMed